Remove Government Remove Healthcare Remove Networking Remove Training
article thumbnail

Championing UK ATMP clinical trials

European Pharmaceutical Review

Specifically, an additional four years of funding for the Advanced Therapy Treatment Centre (ATTC) Network is available through the programme. The funding will start with three established Centres, and then across an expanded network, according to Chief Clinical Officer for Cell and Gene Therapy Catapult, Jacqueline Barry.

article thumbnail

Data integrity considerations in Pharma and Life Sciences

European Pharmaceutical Review

Life science companies are increasingly using advanced technologies like artificial intelligence (AI), machine learning (ML) and blockchain to improve data quality and integrity by detecting anomalies in data and establishing tamper-proof audit trails for all data-related activities Data governance. Training and education.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ESG Top Trends: Technology trends

Pharmaceutical Technology

The pharma industry has deeply rooted environmental, social, and governance (ESG) issues that challenge sustainability. Listed below are the key technology trends impacting the ESG performance in the healthcare sector, as identified by GlobalData. Orthopaedic companies have been using 3D printing for their implants for years.

article thumbnail

The danger of COVID conspiracy theorists

World of DTC Marketing

In a study that included 9654 US adults, 48% of those who had a high school education or less believed there was some truth to the conspiracy theory that COVID-19 was planned but only 15% among those with some postgraduate training endorsed this idea” But what about those who have an education and still believe and spread COVID misinformation?

article thumbnail

Why Is FDA Issuing Fewer Marketing Violation Letters?

Pharma Marketing Network

As new healthcare challenges arise and the pharmaceutical landscape evolves, the FDA may be allocating its resources to focus on other pressing issues, such as drug approvals, monitoring emerging health threats, and enhancing drug safety. appeared first on Pharma Marketing Network.

article thumbnail

Career Changes for Nurses: New Opportunities for Your Skills and Experience

Rep-Lite

It offers an array of opportunities in various healthcare settings. They seek fresh challenges that stimulate their intellectual curiosity and provide a new perspective on the healthcare industry. The horizons expand, and new doors open, offering fresh perspectives while playing their role in healthcare facilities.

article thumbnail

Nixon Gwilt Law Expands Corporate, M&A, and Venture Capital Capabilities with Four New Attorneys

Nixon Gwilt Law

Nixon Gwilt Law (NGL) is excited to announce a significant expansion of our core capabilities through the addition of four attorneys with expertise in healthcare mergers and acquisitions , fundraising and venture capital , and corporate/business counsel. William added, “NGL is leading the way in serving healthcare innovators.